Bulltick Wealth Management LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 273.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,159 shares of the healthcare conglomerate's stock after purchasing an additional 2,314 shares during the period. Bulltick Wealth Management LLC's holdings in UnitedHealth Group were worth $1,598,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $30,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
A number of brokerages recently issued reports on UNH. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. KeyCorp cut their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. JPMorgan Chase & Co. dropped their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Morgan Stanley lowered their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $596.86.
Read Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
NYSE UNH traded down $9.60 during trading hours on Tuesday, hitting $395.21. 7,831,081 shares of the company's stock traded hands, compared to its average volume of 4,648,576. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $393.11 and a 52 week high of $630.73. The firm has a market capitalization of $359.73 billion, a P/E ratio of 25.50, a P/E/G ratio of 1.37 and a beta of 0.56. The business's fifty day moving average price is $493.20 and its two-hundred day moving average price is $526.12.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the firm posted $6.91 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.13%. UnitedHealth Group's payout ratio is presently 35.18%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.